Please ensure Javascript is enabled for purposes of website accessibility

Gilead Sciences(GILD)

Nasdaq Global Select

GILD
Gilead Sciences Stock Quote
$67.24 $0.25 0.4%
Price as of October 22, 2021, 4:00 p.m. ET View Interactive GILD Charts

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

Interactive Chart


Compare GILD Stock to Peers


Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr
GILD
Gilead Sciences
$67.24 $84B 16.1% 7.7%
ILMN
$409.15 $64B 29.5% 189.3%
EXEL
$21.40 $7B -2.1% 88.9%
BMY
$57.60 $128B -0.6% 36.3%
VRTX
$183.52 $49B -11.5% 137.6%

News & Analysis: Gilead Sciences

The Fool has written over 1000 articles on Gilead Sciences.

All

Market Moves

Podcasts